Retirement Systems of Alabama Sells 323 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Retirement Systems of Alabama reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 1.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,923 shares of the company’s stock after selling 323 shares during the period. Retirement Systems of Alabama’s holdings in Henry Schein were worth $2,036,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in HSIC. American Century Companies Inc. boosted its stake in Henry Schein by 3.1% in the 2nd quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock worth $351,543,000 after purchasing an additional 162,477 shares during the period. FMR LLC grew its stake in Henry Schein by 7.8% during the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock valued at $239,177,000 after acquiring an additional 237,888 shares in the last quarter. Southpoint Capital Advisors LP increased its holdings in Henry Schein by 30.0% during the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after acquiring an additional 600,000 shares during the period. Nuance Investments LLC lifted its stake in Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after purchasing an additional 414,748 shares in the last quarter. Finally, Burgundy Asset Management Ltd. boosted its holdings in Henry Schein by 1.0% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock valued at $105,148,000 after purchasing an additional 16,476 shares during the period. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.14% of the stock is currently owned by company insiders.

Henry Schein Trading Up 1.3 %

HSIC stock opened at $69.82 on Friday. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The company has a market capitalization of $8.71 billion, a PE ratio of 28.73, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87. The company’s 50 day moving average price is $72.39 and its two-hundred day moving average price is $70.13. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.05. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s revenue for the quarter was up .4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.32 earnings per share. As a group, analysts predict that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on HSIC shares. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Evercore ISI raised their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Barrington Research reissued an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a report on Wednesday, November 6th. Finally, Mizuho started coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Seven research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $78.89.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.